Infectious Diseases Journal Of Pakistan 03/2011; 20(01):269-272.
Antimicrobial Susceptibility pattern of Acinetobacter spp against piperacillin sulbactam and tigecycline was 64% and 63% respectively where as susceptibility against Sulbactam/cefoperazone, piperacillin/tazobactam and imipenem was 48%, 47% and 41% respectively. Out of 276 isolates studied 66% were multidrug resistant while 18% were pan drug resistant.
[Show abstract][Hide abstract] ABSTRACT: Objective: Ventilator associated pneumonia (VAP) is a common complication among patients admitted to the intensive care units (ICU). Local research lacks data regarding its incidence in general or the immunocompromised population. In this study,we aim to determine the incidence and common etiological agents of ventilator associated pneumonia in cancer patients admitted to the intensive care unit (ICU) of a major tertiary care hospital in Pakistan.
Methods: This study was conducted retrospectively by reviewing medical records of cancer patients admitted in the ICU from January 2010 till September 2012.
Results: Out of the 2032 patients admitted into the ICU, 737 (36.3%) were mechanically ventilated. 23 (3.1%) of these fulfilled the diagnostic criteria for VAP (as per National Healthcare Safety Network); 10 (43.5%) of these patients suffered from solid organ malignancies while 12 (52.2%) suffered with haematological malignancies. The attributable mortality due to VAP was 60.9%, with 60% mortality in solid organ malignancies and 58.3% mortality in haematological malignancies. VAP rates ranged from 29.4 to 3.2. The most common pathogens identified were Acinetobacter baumannii, followed by members of Enterobacteriaceae family and Candida albicans.
Conclusions: VAP rates in cancer patients in our institute are high with a high mortality rate.
Key Words: Ventilator Associated Pneumonia, Cancer Patients, Intensive Care Unit
Note: This list is based on the publications in our database and might not be exhaustive.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.